Context Therapeutics Inc. (CNTX) DCF Valuation

Context Therapeutics Inc. (CNTX) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Context Therapeutics Inc. (CNTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of Context Therapeutics Inc. (CNTX) with our user-friendly DCF Calculator! Enter your projections for growth, profit margins, and expenses to calculate the intrinsic value of Context Therapeutics Inc. (CNTX) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 .0 -10.5 -14.8 -25.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 5.4 2.6 -3.1 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -5.4 -2.6 -7.4 -14.8 -25.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .2 .3 49.6 35.5 14.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.1 2.7 1.8 .9 2.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.3 -.5 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -6.3 -2.6 -5.3 -14.3 -25.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 1.1 .6 -9.5 -15.7 -23.6 -2.4 .0 .0 .0 .0
WACC, % 15.05 15.05 15.05 15.05 15.05 15.05 15.05 15.05 15.05 15.05
PV UFCF
SUM PV UFCF -2.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -14
Equity Value 12
Diluted Shares Outstanding, MM 16
Equity Value Per Share 0.78

What You Will Get

  • Real CNTX Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Context Therapeutics' future performance.
  • User-Friendly Design: Designed for industry professionals but easy for newcomers to navigate.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical performance and future forecasts for Context Therapeutics Inc. (CNTX).
  • Adjustable Forecast Parameters: Modify highlighted cells for key variables such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to help you interpret your valuation outcomes.
  • Designed for All Levels: A straightforward layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template containing Context Therapeutics Inc.'s (CNTX) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Context Therapeutics Inc.'s (CNTX) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator for Context Therapeutics Inc. (CNTX)?

  • Designed for Industry Experts: A specialized tool utilized by healthcare analysts, CFOs, and biotech consultants.
  • Comprehensive Data: Context Therapeutics' historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions to explore potential outcomes.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and other essential metrics.
  • User-Friendly Interface: Clear, step-by-step guidance helps you navigate through the calculations.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for analyzing Context Therapeutics Inc. (CNTX) investments.
  • Biotech Research Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Financial Consultants: Deliver precise valuation insights for clients interested in Context Therapeutics Inc. (CNTX).
  • Students and Instructors: Utilize real-world data to practice and teach financial modeling in the biotech sector.
  • Pharmaceutical Enthusiasts: Gain an understanding of how biotech firms like Context Therapeutics Inc. (CNTX) are valued in the market.

What the Template Contains

  • Preloaded CNTX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.